HIGHLIGHTS
- who: Sebastian W. Schleser and collaborators from the Organic Chemistry, University of Bayreuth, Universitu00e4tsstrasse, Bayreuth, Germany have published the paper: New 4,5-Diarylimidazol-2-ylidene-iodidogold(I) Complexes with High Activity against Esophageal Adenocarcinoma Cells, in the Journal: (JOURNAL)
- what: The NHC ligand system of a previously published anticancer active iodidogold(I)- NHC complex was successfully optimized in terms of anticancer properties, and high activities against EAC cells were achieved for several new gold complexes.
- how: Experimental data were examined using an unpaired two-tailed t-test by comparing to the corresponding . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.